Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

Share Price is delayed by 15 minutes
Get Live Data
16.25    0.00 (0.00%)
Bid:
16.00
Ask:
16.50
Spread: 0.50 (3.125%)
Market Cap: £8.88m
VEL Live PriceLast checked at - London Stock Exchange

Intraday Velocity Comp Share Chart

Director/PDMR Shareholding

16 Oct 2019 07:00

RNS Number : 9993P
Velocity Composites PLC
16 October 2019
 

16 October 2019

 

Velocity Composites plc 

(the "Company")

 

Director/PDMR Shareholding

 

Velocity Composites plc, the leading supplier of advanced composite material kits, providing engineering value-solutions for the global aerospace industry, has been informed that Andy Beaden, non-executive Chairman of the Company, purchased 50,000 ordinary shares of 0.25 pence each ("Ordinary Shares") on 15 October 2019 at an average price of 18.49 pence per Ordinary Share.

Mr. Beaden had no previous shareholding in the Company. Consequently, he now has a beneficial interest in 50,000 Ordinary Shares representing approximately 0.14% of the issued share capital of the Company. 

Enquiries

 

Velocity

Jon Bridges, CEO

 

 

01282 577 577

Cenkos Securities plc

(Nominated Adviser)

Russell Cook

Ben Jeynes

 

 

020 7397 8900

 

Camarco

(Financial PR)

Ed Gascoigne Pees

Georgia Edmonds

James Crothers

 

020 3757 4980

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Michael Beaden

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Velocity Composites plc

b)

LEI

213800W4W46J8HGZP672

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.25p each

 

Identification code

GB00BF339H01

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

£0.1900£0.1899£0.1894£0.1800

5,00010,00010,00025,000

d)

Aggregated information

N/A single transaction

 

Aggregated volume

N/A single transaction

 

Price

N/A single transaction

e)

Date of the transaction

15 October 2019

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFELLFKBFBFBD
Date   Source Headline
26th May 20267:00 amRNSTrading Statement
6th May 20269:07 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSBoard Change
23rd Mar 20262:18 pmRNSGrant of Share Options to Directors/PDMRs
17th Mar 202611:11 amRNSResult of AGM
9th Feb 202612:15 pmRNSChange of Joint Broker
27th Jan 202612:42 pmRNSReplacement - Audited Final Results
27th Jan 20267:00 amRNSFinal Results to the 31 October 2025
13th Jan 20263:49 pmRNS-RNotice of Investor Presentation - Replacement
8th Jan 20267:00 amRNS-RNotice of Investor Presentation
27th Nov 202510:19 amRNSPDMR/Director shareholding
25th Nov 202511:18 amRNSGrant of Share Options to Directors/PDMRs
5th Nov 20257:00 amRNSTrading Update
8th Oct 20257:00 amRNSContract Renewal and Expansion
8th Jul 202510:43 amRNSExercise of Share Options and Issue of Equity
25th Jun 20257:00 amRNSUnaudited Half Year Results
29th May 20257:00 amRNS-RNotice of Investor Presentation
22nd May 20257:00 amRNSTrading Update & Notice of Results
14th May 20253:16 pmRNSExercise of Share Options and Issue of Equity
12th May 20257:00 amRNSRenewal of BAE Systems Contract
6th May 20254:53 pmRNSHolding(s) in Company
6th May 202510:41 amRNSHolding(s) in Company
29th Apr 20255:26 pmRNSExercise of Share Options and Issue of Equity
28th Apr 20254:37 pmRNSPublication of Annual Report and Accounts
28th Mar 20252:49 pmRNSExercise of Share Options and Issue of Equity
17th Mar 20251:51 pmRNSDirector/PDMR Shareholding
11th Mar 202512:15 pmRNSResult of AGM
5th Mar 202510:53 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RAppointment of Chief Operations Officer
3rd Feb 20257:00 amRNSGrant of Share Options
29th Jan 20257:00 amRNSAudited Final Results to 31 October 2024
15th Jan 20257:00 amRNS-RNotice of Investor Presentation
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20243:26 pmRNSExercise of Share Options and Issue of Equity
12th Dec 20247:00 amRNSTrading Update & Notice of Results
4th Nov 20244:43 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
7th Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 20245:48 pmRNSExercise of Share Options and Issue of Equity
18th Sep 20247:00 amRNSTrading Update
17th Jul 202410:16 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSHalf-Year Results
22nd May 20247:00 amRNSTrading Update & Notice of Results
13th May 20245:12 pmRNSReplacement: Holding(s) in Company
13th May 20242:31 pmRNSHolding(s) in Company
2nd May 20247:00 amRNSChange of Nominated Adviser and Corporate Broker
8th Apr 20244:38 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.